Trial Profile
The Influence of Iatrogenic Chronotropic Incompetence on Exercise Tolerance in Pacemaker Patients With Chronic Heart Failure.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Jan 2020
Price :
$35
*
At a glance
- Drugs Ivabradine (Primary)
- Indications Chronic heart failure
- Focus Therapeutic Use
- Acronyms TREPPE
- 09 Dec 2019 Status changed from recruiting to completed.
- 30 Sep 2014 New trial record
- 29 Sep 2014 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record..